scispace - formally typeset
H

Hongfeng Deng

Researcher at GlaxoSmithKline

Publications -  24
Citations -  1814

Hongfeng Deng is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Cannabinoid & Receptor. The author has an hindex of 18, co-authored 24 publications receiving 1689 citations. Previous affiliations of Hongfeng Deng include University of Connecticut.

Papers
More filters
Journal ArticleDOI

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

TL;DR: AM1241 dose-dependently reversed tactile and thermal hypersensitivity produced by ligation of the L5 and L6 spinal nerves in rats, demonstrating a mechanism leading to the inhibition of pain, one that targets receptors localized exclusively outside the CNS.
Journal ArticleDOI

CB2 cannabinoid receptor-mediated peripheral antinociception.

TL;DR: Using AM1241, a CB2 receptor‐selective agonist, it is demonstrated that CB2 receptors produce antinociception to thermal stimuli and the local, peripheral nature of CB2 cannabinoid antinOCiception is demonstrated.
Patent

Cannabimimetic indole derivatives

TL;DR: In this article, a novel cannabimimetic indole derivatives are presented which have preferentially high affinities for one of the cannabinoid CB1 or CB2 receptor sites.